Skip to main content
C&R Research Inc. logo

C&R Research Inc. — Investor Relations & Filings

Ticker · 359090 ISIN · KR7359090008 KO Professional, scientific and technical activities
Open in API
Filings indexed 164 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country KR South Korea
Listing KO 359090

About C&R Research Inc.

https://www.cnrres.com/

C&R Research Inc. is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. The company's offerings span the entire product lifecycle, from early-phase development and clinical trial design to regulatory affairs, data management, statistical consulting, and trial management. C&R Research is actively transitioning into a 'Data CRO' by integrating artificial intelligence (AI), Real-World Data (RWD), and platform-based solutions to enhance the efficiency and quality of clinical trials. The organization supports global studies, including navigating regulatory submissions with international bodies such as the U.S. FDA, and has demonstrated expertise in complex therapeutic areas like oncology, advanced biologics, and innovative medical devices.

Recent filings

Filing Released Lang Actions
주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)
Regulatory Filings Classification · 90% confidence The document is a brief regulatory notice in Korean announcing a suspension of stock trading (“주권매매거래정지”) due to a share consolidation event. It contains no financial statements or management discussion but is a compliance/market notice. This aligns with the ‘Regulatory Filings’ category for miscellaneous regulatory announcements (RNS).
2026-06-02 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 88% confidence The document is titled "분기보고서 (제 7 기) 2026년 01월 01일~2026년 03월 31일" and contains comprehensive sections typical of a quarterly (interim) report: company overview, business descriptions, capital changes, share statistics, and is clearly the full report itself rather than an announcement. It contains substantive financial and operational information for a quarter, satisfying the criteria for an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' which translates to 'Extraordinary General Meeting (EGM) Results'. It provides details on the date of the meeting, the record date for voting rights, and the voting results on specific agenda items such as stock consolidation and amendments to the articles of incorporation. The document is short (1241 characters) and focuses solely on the official voting results of the shareholders at the meeting. There is no detailed financial data, management discussion, or presentation materials included. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting (AGM or EGM).
2026-05-07 Korean
불성실공시법인지정 (공시불이행 1건, 공시변경 1건)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement regarding designation as a '불성실공시법인' (an entity designated for non-compliance or improper disclosure) due to delayed and changed disclosures related to a single sales and supply contract. It includes details about penalties, dates of violations, and regulatory references to the KOSDAQ market disclosure rules. The document is short (1361 characters) and does not contain financial statements or detailed financial data. It is an official regulatory filing about disclosure compliance issues rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2026-05-06 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a brief announcement about a change in the company's department affiliation from '벤처기업부' (Venture Business Department) to '중견기업부' (Mid-sized Business Department). It contains no financial data, no mention of reports, no regulatory filings, or other detailed information. It is a simple corporate update about organizational change, which fits best under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2026-04-30 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 90% confidence The document is clearly a Notice of Convocation for the 7th Extraordinary General Meeting (임시주주총회 소집공고) of C&R Research Co., Ltd., providing shareholders with the meeting date, location, agenda items (including share consolidation and amendments to the articles), detailed background information and materials to enable informed voting. This matches the description of materials sent to shareholders to provide information and solicit votes for a meeting (Proxy Solicitation & Information Statement).
2026-04-22 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.